IT · NSE: ZENSARTECH
Zensar Technologies
Q2 FY27 earnings highlights, from the results presentation
Q2 FY27 · From the investor presentation
- M.Cap
- ₹12,269Cr
- P/E
- 15.6×
- 1Y return
- −25.63%
- From 52W high
- −29.0%
Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.
Share price
Results Q2 FY27, as filed · consolidated · ₹ Cr
| Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ | |
|---|---|---|---|---|---|
| Revenue | 1,585 | 1,421 | +11.5% | 1,508 | +5.1% |
| EBITDA | 250 | 220 | +13.5% | 221 | +13.0% |
| EBITDA margin | 15.8% | 15.5% | +27 bps | 14.7% | +110 bps |
| PBTProfit before tax | 252 | 240 | +4.9% | 246 | +2.3% |
| Net profit | 190 | 182 | +4.4% | 184 | +3.5% |
| EPS (₹) | 8.28 | 7.93 | +4.4% | 7.99 | +3.6% |
From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.
In short
- 01Q2 FY27 revenue was $166.2M, up 4.1% quarter on quarter in constant currency.
- 02EBITDA margin was 15.8%, up 120 bps from the prior quarter.
- 03Order book stood at $151.5M; AI-influenced deals were 36% of it.
- 04BFSI grew 7.1% QoQ and 17.1% YoY in constant currency; TMT fell 21.6% YoY.
- 05Management says demand is supported by investment in AI and digital modernization.
- 06Cash and investments were $297.3M with no debt.
- 07Utilization excluding trainees rose to 87.6%; headcount reached 12,320.
Order book
AI-influenced deals are 36% of the Q2 FY27 order book
Slides · CEO and Managing Director · p. 2
AI-influenced deals are 36% of the Q2 FY27 order book
“AI-influenced deals now represent 36% of our order book for Q2FY27, demonstrating growing client confidence in our AI-led capabilities.”
Order book at $151.5M in Q2 FY27
Slides · p. 15
Order book at $151.5M in Q2 FY27
“Order book Attrition $151.5M 9.3%”
Segments
US: US revenue up 4.5% QoQ and 2.5% YoY in constant currency
Slides · p. 2
US: US revenue up 4.5% QoQ and 2.5% YoY in constant currency
“US region registered a QoQ revenue growth of 4.5% and quarterly YoY growth of 2.5% in constant currency.”
Europe: Europe revenue up 1.3% QoQ and 0.3% YoY in constant currency
Slides · p. 2
Europe: Europe revenue up 1.3% QoQ and 0.3% YoY in constant currency
“Europe region registered a QoQ revenue growth of 1.3% and quarterly YoY growth of 0.3% in constant currency.”
Africa: Africa revenue up 6.7% QoQ and 2.2% YoY in constant currency
Slides · p. 2
Africa: Africa revenue up 6.7% QoQ and 2.2% YoY in constant currency
“Africa region registered a QoQ revenue growth of 6.7% and quarterly YoY growth of 2.2% in constant currency.”
Banking and Financial Services: Banking and Financial Services up 7.1% QoQ and 17.1% YoY in constant currency
Slides · p. 2
Banking and Financial Services: Banking and Financial Services up 7.1% QoQ and 17.1% YoY in constant currency
“Banking and Financial Services registered a QoQ revenue growth of 7.1% and quarterly YoY growth of 17.1% in constant currency.”
Healthcare and Life Sciences: Healthcare and Life Sciences up 2.4% QoQ, down 9.9% YoY in constant currency
Slides · p. 2
Healthcare and Life Sciences: Healthcare and Life Sciences up 2.4% QoQ, down 9.9% YoY in constant currency
“Healthcare and Life Sciences registered a QoQ revenue growth of 2.4% and quarterly YoY decline of 9.9% in constant currency.”
Demand
Demand supported by continued investment in AI and digital modernization
Slides · Chief Financial Officer · p. 2
Demand supported by continued investment in AI and digital modernization
“The demand environment today is largely supported by continued investments in AI & digital modernization.”
CFO expects next phase of growth to favour firms combining AI, domain and secure execution
Slides · Chief Financial Officer · p. 2
CFO expects next phase of growth to favour firms combining AI, domain and secure execution
“We believe the next phase of growth will favour organizations that can pivot seamlessly into newer trends, combine AI capabilities, domain expertise, and secure execution at scale.”
Margins and costs
Q2 FY27 EBITDA at 15.8% of revenue, up 120 bps QoQ
Slides · p. 2
Q2 FY27 EBITDA at 15.8% of revenue, up 120 bps QoQ
“In Q2FY27, the company reported EBITDA at 15.8% of revenue, a QoQ increase of 120 bps.”
Gross margin 29.5% in Q2 FY27, from 31.0% a year earlier
Slides · p. 8
Gross margin 29.5% in Q2 FY27, from 31.0% a year earlier
“Gross profit % of revenue 31.0% 31.9% 29.7% 29.5%”
Other margin impact from higher AMC and software costs and revenue shore mix
Slides · p. 18
Other margin impact from higher AMC and software costs and revenue shore mix
“*Other margin impact includes increase in AMCs and software related cost & change in revenue shore mix”
EBIT margin 13.4% in Q2 FY27, from 12.7% in Q1 FY27
Slides · p. 8
EBIT margin 13.4% in Q2 FY27, from 12.7% in Q1 FY27
“EBIT % of revenue 13.6% 14.4% 12.7% 13.4%”
Operating expenses $22.8M in Q2 FY27, from $24.1M in Q1 FY27
Slides · p. 8
Operating expenses $22.8M in Q2 FY27, from $24.1M in Q1 FY27
“Operating expenses 25.3 102.5 24.1 22.8”
Debt and working capital
CFO says balance sheet remains robust for strategic investments
Slides · Chief Financial Officer · p. 2
CFO says balance sheet remains robust for strategic investments
“We continue to maintain a robust balance sheet, enabling us to pursue strategic investments and capitalize on emerging technology trends.”
Cash and investments at $297.3M in Q2 FY27, from $317.5M in Q1
Slides · p. 11
Cash and investments at $297.3M in Q2 FY27, from $317.5M in Q1
“Cash and bank balances including investments 293.0 319.5 317.5 297.3”
Total receivables at 77 days; unbilled up to 35 days
Slides · p. 11
Total receivables at 77 days; unbilled up to 35 days
“Unbilled 28 24 27 35 Total 75 78 75 77”
Total outstanding hedges at $70.8M in Q2 FY27
Slides · p. 11
Total outstanding hedges at $70.8M in Q2 FY27
“Total Outstanding Hedges (in USD Mn) 80.2 72.6 77.0 70.8”
Acquisitions and new business
ZenseAI suite moving from proof of value to production-scale adoption at several clients
Slides · CEO and Managing Director · p. 2
ZenseAI suite moving from proof of value to production-scale adoption at several clients
“Building on the momentum of our ZenseAI suite, we are progressing from proof of value to production-scale adoption across several clients.”
Risks
Top 5 clients were 25.0% of revenue in Q2 FY27
Slides · p. 11
Top 5 clients were 25.0% of revenue in Q2 FY27
“Revenue- top 5 clients 27.0% 26.0% 24.7% 25.0%”
Other
Q2 FY27 revenue $166.2M, up 4.1% QoQ in constant currency
Slides · p. 2
Q2 FY27 revenue $166.2M, up 4.1% QoQ in constant currency
“In Q2FY27, the company posted revenue of $166.2M, sequential quarter constant currency growth of 4.1%.”
Voluntary attrition (LTM) at 9.3% in Q2 FY27
Slides · p. 11
Voluntary attrition (LTM) at 9.3% in Q2 FY27
“Voluntary Attrition %(LTM) 9.8% 9.8% 9.6% 9.3%”
Total headcount 12,320 in Q2 FY27, from 11,342 in Q1
Slides · p. 11
Total headcount 12,320 in Q2 FY27, from 11,342 in Q1
“Total Headcount 10,550 10,779 11,342 12,320”
Q2 FY27 PAT $20.0M, down 4.0% YoY in USD
Slides · p. 7
Q2 FY27 PAT $20.0M, down 4.0% YoY in USD
“PAT 20.0 1,902 2.8% 3.4% (4.0)% 4.3%”
Clients with $20M+ LTM revenue rose to 7 from 6
Slides · p. 10
Clients with $20M+ LTM revenue rose to 7 from 6
“20 Million dollar + 6 6 6 7”
Sources
- Investor presentation, Q2 FY27 Filed 28 Oct 2026 · 27 pages
Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

